CWGCX
Price
$68.12
Change
+$0.24 (+0.35%)
Updated
Jun 6 closing price
Net Assets
130.86B
RGLHX
Price
$25.77
Change
+$0.12 (+0.47%)
Updated
Jun 6 closing price
Net Assets
16.75B
Interact to see
Advertisement

CWGCX vs RGLHX

Header iconCWGCX vs RGLHX Comparison
Open Charts CWGCX vs RGLHXBanner chart's image
American Funds Capital World Gr&Inc C
Price$68.12
Change+$0.24 (+0.35%)
VolumeN/A
Net Assets130.86B
American Funds Global Insight R-2E
Price$25.77
Change+$0.12 (+0.47%)
VolumeN/A
Net Assets16.75B
CWGCX vs RGLHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CWGCX vs. RGLHX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a Buy and RGLHX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 131B vs. RGLHX (16.7B). CWGCX pays higher dividends than RGLHX: CWGCX (0.87) vs RGLHX (0.46). CWGCX was incepted earlier than RGLHX: CWGCX (24 years) vs RGLHX (6 years). CWGCX (1.49) is less costly to investors than RGLHX (1.24). CWGCX is a more actively managed with annual turnover of: 27.00 vs. RGLHX (21.00). CWGCX (250) and RGLHX (250) have matching initial minimum investment requirements. RGLHX annual gain was more profitable for investors over the last year : 12.10 vs. CWGCX (5.53). RGLHX return over 5 years is better than : 57.80 vs. CWGCX (42.30).
CWGCXRGLHXCWGCX / RGLHX
Total Expense Ratio1.491.24120%
Annual Report Gross Expense Ratio1.491.24120%
Fund Existence24 years6 years-
Gain YTD8.71110.17586%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets131B16.7B784%
Annual Yield % from dividends0.870.46189%
Returns for 1 year5.5312.1046%
Returns for 3 years26.8636.7973%
Returns for 5 years42.3057.8073%
Returns for 10 years49.31N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV6.200.47
+8.12%
Verve Therapeutics
PIII6.620.14
+2.24%
P3 Health Partners Inc
VSAT9.210.09
+0.99%
ViaSat
NLY19.060.18
+0.95%
Annaly Capital Management
RELI1.47-0.04
-2.65%
Reliance Global Group Inc.